Literature DB >> 8314420

Association of elevated serum uric acid with coronary heart disease in diabetes mellitus.

W Rathmann1, H Hauner, K Dannehl, F A Gries.   

Abstract

The relationship between elevated serum uric acid (SUA) and coronary heart disease (CHD) is discussed controversially. In this cross-sectional study, we evaluated the association between hyperuricaemia and small- and large-vessel diseases in diabetic patients by analyzing clinical data of 7847 diabetic patients of both sexes (Type 1 diabetes: n = 3800, Type 2 diabetes: n = 4047). Elevated serum uric acid was defined as concentrations > 7.0 mg/dl in men and > 6.6 mg/dl in women. The prevalence of hyperuricaemia was dependent on age and duration of the disease in Type 1 diabetic patients, whereas in recently diagnosed Type 2 diabetic patients the prevalence of elevated uric acid levels was higher than in patients with long-standing Type 1 diabetes, without any further increase with longer duration of the disease. An elevated uric acid level was also associated with body weight, hypertension and nephropathy in both types of diabetes and in both sexes. In women, hyperuricaemia was correlated with the presence of coronary heart disease both in Type 1 and Type 2 diabetes (p < 0.05). The exclusion of hypertension and nephropathy in the multiple logistic regression had no effect on these associations. However, after adjustment for these two factors a significant correlation between hyperuricaemia and coronary heart disease was also found in Type 2 diabetic men. In addition, increased serum uric acid was associated with gangrene in male Type 2 diabetic patients (p < 0.05). These results suggest that elevated uric acid levels are correlated with the presence of coronary heart disease in female rather than in male diabetic patients, independently of hypertension and nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314420

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  12 in total

Review 1.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 2.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

Review 3.  The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review.

Authors:  G Zoppini; G Targher; E Bonora
Journal:  J Endocrinol Invest       Date:  2011-12       Impact factor: 4.256

4.  Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Incident Ischemic Heart Disease in Non-Diabetic Koreans.

Authors:  Byoungjin Park; Dong-Hyuk Jung; Yong-Jae Lee
Journal:  Biomedicines       Date:  2022-06-15

5.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

6.  Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.

Authors:  W S Waring; J A McKnight; D J Webb; S R J Maxwell
Journal:  Diabetologia       Date:  2007-10-10       Impact factor: 10.122

7.  Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease.

Authors:  Ticiana C Rodrigues; David M Maahs; Richard J Johnson; Diana I Jalal; Gregory L Kinney; Christopher Rivard; Marian Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2010-08-26       Impact factor: 17.152

8.  Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus.

Authors:  Hiroyuki Ito; Mariko Abe; Mizuo Mifune; Koshiro Oshikiri; Shinichi Antoku; Yuichiro Takeuchi; Michiko Togane
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

9.  Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.

Authors:  D Conen; V Wietlisbach; P Bovet; C Shamlaye; W Riesen; F Paccaud; M Burnier
Journal:  BMC Public Health       Date:  2004-03-25       Impact factor: 3.295

10.  Serum urate and cardiovascular events in the DCCT/EDIC study.

Authors:  Alicia J Jenkins; Barbara H Braffett; Arpita Basu; Ionut Bebu; Samuel Dagogo-Jack; Trevor J Orchard; Amisha Wallia; Maria F Lopes-Virella; W Timothy Garvey; John M Lachin; Timothy J Lyons
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.